Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer

Nirmish Singla, Ahmed Q. Haddad, Niccolo M. Passoni, Matthew Meissner, Yair Lotan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalWorld Journal of Urology
DOIs
StateAccepted/In press - May 18 2016

Fingerprint

Mycobacterium bovis
Urinary Bladder Neoplasms
Anti-Inflammatory Agents
Cystectomy
Databases
Pathology
Muscles
Therapeutics

Keywords

  • Anti-inflammatory agents
  • BCG
  • Intravesical therapy
  • Non-muscle-invasive bladder cancer

ASJC Scopus subject areas

  • Urology

Cite this

Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer. / Singla, Nirmish; Haddad, Ahmed Q.; Passoni, Niccolo M.; Meissner, Matthew; Lotan, Yair.

In: World Journal of Urology, 18.05.2016, p. 1-7.

Research output: Contribution to journalArticle

@article{4947429e21184bd28be7b15af72e40da,
title = "Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer",
abstract = "Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had",
keywords = "Anti-inflammatory agents, BCG, Intravesical therapy, Non-muscle-invasive bladder cancer",
author = "Nirmish Singla and Haddad, {Ahmed Q.} and Passoni, {Niccolo M.} and Matthew Meissner and Yair Lotan",
year = "2016",
month = "5",
day = "18",
doi = "10.1007/s00345-016-1853-z",
language = "English (US)",
pages = "1--7",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer

AU - Singla, Nirmish

AU - Haddad, Ahmed Q.

AU - Passoni, Niccolo M.

AU - Meissner, Matthew

AU - Lotan, Yair

PY - 2016/5/18

Y1 - 2016/5/18

N2 - Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had

AB - Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had

KW - Anti-inflammatory agents

KW - BCG

KW - Intravesical therapy

KW - Non-muscle-invasive bladder cancer

UR - http://www.scopus.com/inward/record.url?scp=84969933373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969933373&partnerID=8YFLogxK

U2 - 10.1007/s00345-016-1853-z

DO - 10.1007/s00345-016-1853-z

M3 - Article

SP - 1

EP - 7

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

ER -